RaySearch Laboratories AB (publ) announced that University Hospitals Seidman Cancer Center/Case Western Reserve University in Cleveland, Ohio, in the USA, has placed an order in December 2022 and chosen to transition to RayStation® as its primary treatment planning system. Revenue from the order will be recognized in the fourth quarter, 2022. University Hospitals Seidman Cancer Center's Department of Radiation Oncology has rapidly transformed into an internationally recognized center of excellence.

They now offer and have signed agreements to provide one of the most diverse array of treatment technologies, including proton therapy, MRI-guided radiotherapy, cobalt-based SRS, intraoperative radiotherapy, brachytherapy, radiopharmaceutical therapy, and high volume SBRT and IMRT/VMAT. UH Seidman Cancer Center is part of the Case Comprehensive Cancer Center, one of the nation's leading academic and research institutions. They have 15 cancer treatment sites, nine with radiation oncology services and have added 53 new team members comprised of top talent from across the United States.

RayStation will be used across the entire network for all photon/electron treatments on Varian and Elekta linear accelerators, as well as for proton treatments with the Mevion proton system. Thus, RayStation will help the departments standardize since it supports treatment planning for multiple treatment machines across several vendors. The centers will utilize the latest RayStation technologies such as deep learning segmentation, image deformation, adaptive planning, Multi Criteria Optimization, and fallback planning, which allows for contingency planning and comparison of modalities to help clinicians select the most appropriate treatment technique.